All stock reports

GSPCROP evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-09T23:42:13.079346+00:00

Metrics

latest_annual_period
2026-03-31
revenue
15151230000.0
net_income
978950000.0
operating_cash_flow
593790000.0
free_cash_flow
-178520000.0
total_assets
15467640000.0
total_liabilities
7764830000.0
total_equity
7716630000.0
cash
1553210000.0
total_debt
Not supplied
revenue_growth
0.18122035494544209
earnings_growth
0.17323825503355694
net_margin
0.06461191599625905
roe
0.12686237386009178
debt_to_equity
Not supplied
cash_conversion
0.6065580468869707
free_cash_flow_margin
-0.011782541747435687
trailing_pe
Not supplied
forward_pe
Not supplied
peg_ratio
Not supplied
price_to_book
Not supplied
dividend_yield
Not supplied

Other positional research

Research only

1 opportunity assessments; compare evidence and conditions below.

Price Dislocation

Research only. Direction: LONG.

Flags large price dislocations for research without asserting unsupported fundamental quality

  • No active, unexpired validation authority for this exact strategy and horizon.
  • A source-backed entry, invalidation, exit and cost plan is not supplied.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Continued price deterioration or adverse fundamental evidence
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
NO_POSITIONAvailableNot suppliedNot suppliedNot supplied0.000.00Not suppliedNo new position; incremental trading P&L is zero.
CASHUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
FUTURESUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
OPTIONSUnavailableNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedNot suppliedObserved contract, quote and cost evidence not supplied.
  • No reader capital or loss budget supplied
Decision provenance and limitations
Decision ID
decision-89c33fdb34ab07c776dfbd8579a58fdd571038222cac12677da12b2cbed28c2d
Policy
stock-decisions-v1
Evidence bundle hash
25d7a248d6da01a670f7b51a9d12fedd934335b4277bc6e6c2332162fb7ead1d
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: dda9d4f53573444219efad5bde898e6c26e07267c11aad805f93adeeb0a29ab0
  • daily-price: 6d6b0e4de10f00270596330c14a973adf952c49c945f9ab0c573181c0e7209b0
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: VERIFIED. The trailing 5-session price return was -7.35%. The trailing 20-session price return was -27.26%. The trailing 60-session price return was 18.43%. Average cached traded value over twenty sessions was INR 228,488,535.

Risks

The closing price was -29.21% below its highest close in the available trailing year. The cached financial metric free cash flow margin is -0.011782541747435687. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

The cached financial metric latest annual period is 2026-03-31. The cached financial metric revenue growth is 0.18122035494544209. The cached financial metric net margin is 0.06461191599625905. The cached financial metric roe is 0.12686237386009178. The cached financial metric cash conversion is 0.6065580468869707.

Cached observations and evidence limits